Back to Journals » Drug Design, Development and Therapy » Volume 16

Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway

Total article views   HTML views PDF downloads Totals
4,671 Dovepress* 4,213+ 90 4,303
PubMed Central* 458 209 667
Totals 4,671 299 4,970
*Since 2 December 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar